References

Uveal melanoma

2018 · External reference

Uveal melanoma: trends in incidence, treatment, and survival

10.1016/j.ophtha.2011.01.040 · 2011 · External reference

Incidence of uveal melanoma in Europe

10.1016/j.ophtha.2007.01.032 · 2007 · External reference

SF3B1 mutations are associated with alternative splicing in uveal melanoma

10.1158/2159-8290.cd-13-0330 · 2013 · External reference

Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3

10.1038/ng.2674 · 2013 · External reference

Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases

10.1016/j.ophtha.2016.01.023 · 2016 · External reference

Prognostic parameters in uveal melanoma and their association with BAP1 expression

10.1136/bjophthalmol-2014-305047 · 2014 · External reference

Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma

10.1167/iovs.14-14550 · 2014 · External reference

Loss of BAP1 is associated with upregulation of the NFkB pathway and increased HLA class I expression in uveal melanoma

10.3390/cancers11081102 · 2019 · External reference

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment

10.1007/s00262-017-1991-1 · 2017 · External reference

Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma

10.1167/iovs.07-0786 · 2008 · External reference

Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma

10.1167/iovs.11-9280 · 2012 · External reference

Neutrophils support lung colonization of metastasis-initiating breast cancer cells

10.1038/nature16140 · 2015 · External reference

Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with bone metastases

10.1038/s41416-018-0231-6 · 2018 · External reference

Macrophages and neutrophils: regulation of the inflammatory microenvironment in autoimmunity and cancer

10.1155/2016/5894347 · 2016 · External reference

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

10.1093/jnci/dju124 · 2014 · External reference

Generation of a double binary transgenic zebrafish model to study myeloid gene regulation in response to oncogene activation in melanocytes

2018 · External reference

IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis

10.1038/nature14282 · 2015 · External reference

Inflammatory markers and overall survival in older adults with cancer

10.1016/j.jgo.2018.08.004 · 2019 · External reference

Predictive value of preoperative lymphocyte-to-monocyte ratio on survival outcomes in bladder cancer patients after radical cystectomy

2021 · External reference

Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma

10.1038/modpathol.2014.43 · 2014 · External reference

Inflammation and cancer: back to Virchow?

10.1016/s0140-6736(00)04046-0 · 2001 · External reference

Inflammation and cancer: causes and consequences

10.1038/clpt.2009.254 · 2010 · External reference

Inflammation and cancer

10.1038/nature01322 · 2002 · External reference

The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer

10.1016/j.critrevonc.2013.03.010 · 2013 · External reference

C-reactive protein as a marker of melanoma progression

10.1200/jco.2014.58.0209 · 2015 · External reference

Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: a pilot study

10.1080/2162402x.2017.1321187 · 2017 · External reference

Uveal melanoma: identifying immunological and chemotherapeutic targets to treat metastases

2017 · External reference

Tebentafusp: T cell redirection for the treatment of metastatic uveal melanoma

10.3390/cancers11070971 · 2019 · External reference

Overall survival benefit with tebentafusp in metastatic uveal melanoma

10.1056/nejmoa2103485 · 2021 · External reference

Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?

10.3389/fimmu.2012.00148 · 2012 · External reference